Stay updated on Pembrolizumab Plus Entinostat in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Added Melanoma and related topics: MedlinePlus Genetics to the related topics section. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-21T04:19:07.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The page's revision tag changes from v3.3.3 to v3.3.4. No substantive changes to the study details are observed.
    Difference
    0.1%
    Check dated 2026-01-14T02:47:49.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Melanoma-related topics, including MedlinePlus Genetics, were removed from the related topics section. This may reduce quick access to melanoma-specific information and related resources on the study page.
    Difference
    0.2%
    Check dated 2025-12-30T19:48:51.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Added Melanoma and related topics (MedlinePlus Genetics), Locations (North Carolina), and updated the revision to v3.3.3, while removing HHS Vulnerability Disclosure and North Carolina Locations.
    Difference
    0.4%
    Check dated 2025-12-23T12:29:30.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    Removed related topics entries for Melanoma and MedlinePlus Genetics from the page. No new core information was added.
    Difference
    0.2%
    Check dated 2025-12-09T00:38:10.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    Revision history updated from v3.2.0 to v3.3.2, affecting only metadata and not the study details. No changes to eligibility, endpoints, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T17:05:43.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Plus Entinostat in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Plus Entinostat in Melanoma Clinical Trial page.